DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target

$18.60 -0.28 (-1.48%)

(As of 12:10 PM ET)

DENTSPLY SIRONA - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 9 Analyst Ratings

Sell
0

Hold
6

Buy
3

Based on 9 Wall Street analysts who have issued ratings for DENTSPLY SIRONA in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 6 have given a hold rating, and 3 have given a buy rating for XRAY.

Consensus Price Target

$29.50
58.60% Upside

According to the 9 analysts' twelve-month price targets for DENTSPLY SIRONA, the average price target is $29.50. The highest price target for XRAY is $42.00, while the lowest price target for XRAY is $24.00. The average price target represents a forecasted upside of 58.60% from the current price of $18.60.

XRAY Analyst Ratings Over Time

Type	Current Forecast 11/21/23 to 11/20/24	1 Month Ago 10/22/23 to 10/21/24	3 Months Ago 8/23/23 to 8/22/24	1 Year Ago 11/21/22 to 11/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	4 Buy rating(s)
Hold	6 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$29.50	$33.22	$33.44	$38.89
Forecasted Upside	58.60% Upside	35.99% Upside	38.54% Upside	25.49% Upside
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Moderate Buy

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

XRAY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

XRAY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

DENTSPLY SIRONA Stock vs. The Competition

Type	DENTSPLY SIRONA	Medical Companies	S&P 500
Consensus Rating Score	2.33	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	56.25% Upside	27,981.07% Upside	9.99% Upside
News Sentiment Rating	Neutral News See Recent XRAY News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/8/2024	Barrington Research 4 of 5 stars		Lower Target	Outperform ➝ Outperform	$36.00 ➝ $24.00	+34.53%
11/8/2024	Robert W. Baird 2 of 5 stars		Lower Target	Neutral ➝ Neutral	$31.00 ➝ $24.00	+39.05%
11/7/2024	Leerink Partnrs 5 of 5 stars	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
11/7/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
10/25/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$34.00 ➝ $29.00	+23.40%
10/8/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$29.00 ➝ $27.00	+11.71%
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover
7/18/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$30.00 ➝ $28.00	+2.04%
5/6/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$34.00 ➝ $30.00	+6.95%
5/3/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral ➝ Neutral	$35.00 ➝ $32.00	+10.92%
11/10/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Vazquez Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform
11/3/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$43.00 ➝ $39.00	+36.65%
5/5/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$43.00 ➝ $46.00	+12.17%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:28 PM ET.

XRAY Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for DENTSPLY SIRONA is $29.50, with a high forecast of $42.00 and a low forecast of $24.00.
: 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" XRAY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
: According to analysts, DENTSPLY SIRONA's stock has a predicted upside of 58.60% based on their 12-month stock forecasts.
: Over the previous 90 days, DENTSPLY SIRONA's stock had 2 downgrades by analysts.
: DENTSPLY SIRONA has been rated by research analysts at Barrington Research, Evercore ISI, Leerink Partners, Leerink Partnrs, Needham & Company LLC, and Robert W. Baird in the past 90 days.
: Analysts like DENTSPLY SIRONA less than other "medical" companies. The consensus rating for DENTSPLY SIRONA is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how XRAY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

👉 Click here to access your FREE report now!

This page (NASDAQ:XRAY) was last updated on 11/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Stock Forecast & Price Target